Levofloxacin prophylaxis in hospitalized children with leukemia: A cost-utility analysis.

Brandon MaserMarie-Claude Pelland-Marcotte Sarah AlexanderLillian SungSumit Gupta

Published in: Pediatric blood & cancer (2020)

The present analysis suggests that levofloxacin prophylaxis, compared to no prophylaxis, is cost saving in children receiving intensive chemotherapy for AML or relapsed ALL.

Keyphrases

acute myeloid leukemia
young adults
acute lymphoblastic leukemia
bone marrow
diffuse large b cell lymphoma
radiation therapy
locally advanced
multiple myeloma
data analysis